Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Coverage Reiterated
Updated: Friday, August 21, 2026 11:22:03 PM
Date
Broker
Company
Symbol
Reiterated
Target
8/21/26
Wedbush
Everpure, Inc.
P
Outperform
$127 Up From $105
8/21/26
Wedbush
Embracer Group B
EMBRAC_B.ST
Neutral
SEK 80 Up From SEK 60
8/21/26
Wedbush
Scholar Rock Holding Corporation
SRRK
Outperform
$64
8/20/26
Wedbush
Telix Pharmaceuticals Limited
TLX
Outperform
$22
8/20/26
BMO Capital
Merck & Co Inc.
MRK
Outperform
$170
8/20/26
BMO Capital
Maplebear Inc.
CART
Outperform
$65
8/20/26
William Blair
BILL Holdings, Inc.
BILL
Market Perform
N/A
8/20/26
William Blair
Sera Prognostics, Inc.
SERA
Outperform
N/A
8/20/26
William Blair
Telix Pharmaceuticals Limited
TLX
Outperform
N/A
8/18/26
William Blair
Birkenstock Holding plc
BIRK
Outperform
N/A
8/17/26
Cantor Fitzgerald
Terreno Realty Corp.
TRNO
Overweight
$77 Up From $75
8/17/26
Wedbush
argenx SE
ARGX
Outperform
$1150 Up From $1050
8/17/26
Wedbush
Cartesian Therapeutics, Inc.
RNAC
Outperform
$38
8/17/26
William Blair
Unity Software Inc.
U
Outperform
N/A
8/17/26
William Blair
Block Inc.
XYZ.AX
Outperform
N/A
8/14/26
Cantor Fitzgerald
National Health Investors, Inc.
NHI
Overweight
$90
8/14/26
Wedbush
Eikon Therapeutics, Inc.
EIKN
Underperform
$4 Down From $5
8/14/26
Wedbush
Nektar Therapeutics
NKTR
Neutral
$80
8/14/26
Wedbush
Replimune Group Inc.
REPL
Outperform
$19
8/13/26
BMO Capital
Bird Construction Inc.
BDT.TO
Outperform
C$85 Up From C$75
8/13/26
BMO Capital
Global-e Online Ltd.
GLBE
Outperform
$48 Up From $46
8/13/26
BMO Capital
Sunshine Silver Mining & Refining Company
SSMR
Outperform
$19.00 Up From $16.50
8/13/26
BMO Capital
Apotex Health Corp
APTX.TO
Outperform
$43
8/13/26
BMO Capital
Ecovyst Inc.
ECVT
Outperform
$16
8/13/26
BMO Capital
Performance Food Group
PFGC
Outperform
$130
8/13/26
BMO Capital
K+S Aktiengesellschaft
SDFG
Outperform
€21
8/13/26
Wedbush
Cerebras Systems, Inc
CBRS
Outperform
$290 Up From $280
8/13/26
Wedbush
First Tracks Biotherapeutics Inc.
TRAX
Outperform
$70 Up From $60
8/13/26
Wedbush
Kura Oncology Inc.
KURA
Outperform
$38 Up From $36
8/13/26
Wedbush
Cullinan Therapeutics, Inc.
CGEM
Outperform
$42 Up From $39
8/13/26
William Blair
Sera Prognostics, Inc.
SERA
Outperform
N/A
8/12/26
Wedbush
Super Micro Computer Inc.
SMCI
Neutral
$40 Up From $34
8/12/26
Wedbush
Immunome, Inc.
IMNM
Outperform
$35 Up From $31
8/12/26
Wedbush
BridgeBio Oncology Therapeutics, Inc.
BBOT
Outperform
$25
8/12/26
Wedbush
National CineMedia Inc.
NCMI
Outperform
$5 Down From $6
8/12/26
William Blair
Aardvark Therapeutics, Inc.
AARD
Outperform
N/A
8/12/26
William Blair
CAVA Group, Inc.
CAVA
Outperform
N/A
8/12/26
William Blair
Black Rock Coffee Bar, Inc.
BRCB
Outperform
N/A
8/11/26
Wedbush
Sana Biotechnology, Inc.
SANA
Outperform
$7
8/11/26
William Blair
Biohaven Ltd.
BHVN
Market Perform
N/A
Buy this Content
Editors Pick
Tesla Recalls 3 Mln Cars In China Over Hidden Door Handles; Shares Drop
August 24, 2026 09:51 ET
Walmart Stock Drops On Weak Q2 Profit, Slower U.S. Comps Growth, Despite Positive Outlook
August 20, 2026 08:43 ET
Target Lifts FY26 Outlook After Q2 Profit Growth On Tariff Benefit, Comps
August 19, 2026 08:30 ET
Home Depot Q2 Results Rise, Backs FY26 View; Expands Express Delivery
August 18, 2026 09:36 ET